Your browser doesn't support javascript.
loading
RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response.
Hofman, I J F; van Duin, M; De Bruyne, E; Fancello, L; Mulligan, G; Geerdens, E; Garelli, E; Mancini, C; Lemmens, H; Delforge, M; Vandenberghe, P; Wlodarska, I; Aspesi, A; Michaux, L; Vanderkerken, K; Sonneveld, P; De Keersmaecker, K.
Afiliação
  • Hofman IJF; KU Leuven - University of Leuven, Department of Oncology, LKI - Leuven Cancer Institute, Leuven, Belgium.
  • van Duin M; Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • De Bruyne E; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussels (VUB), Brussels, Belgium.
  • Fancello L; KU Leuven - University of Leuven, Department of Oncology, LKI - Leuven Cancer Institute, Leuven, Belgium.
  • Mulligan G; Takeda Pharmaceuticals International Co., Cambridge, MA, USA.
  • Geerdens E; Center for Human Genetics, KU Leuven - University of Leuven, Center for Human Genetics, LKI - Leuven Cancer Institute, Leuven, Belgium.
  • Garelli E; Center for the Biology of Disease, VIB Center for the Biology of Disease, Leuven, Belgium.
  • Mancini C; Dipartimento Scienze della Sanità Pubblica e Pediatriche, Univ.Torino, Torino, Italy.
  • Lemmens H; Dipartimento di Scienze Mediche, Univ.Torino, Torino, Italy.
  • Delforge M; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium.
  • Vandenberghe P; Department of Hematology, University Hospital Leuven, Leuven, Belgium.
  • Wlodarska I; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium.
  • Aspesi A; Center for Human Genetics, KU Leuven - University of Leuven, Center for Human Genetics, LKI - Leuven Cancer Institute, Leuven, Belgium.
  • Michaux L; Department of Health Sciences, Universita' del Piemonte Orientale, Novara, Italy.
  • Vanderkerken K; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium.
  • Sonneveld P; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussels (VUB), Brussels, Belgium.
  • De Keersmaecker K; Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands.
Leukemia ; 31(8): 1706-1714, 2017 08.
Article em En | MEDLINE | ID: mdl-27909306
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Ribossômicas / Cromossomos Humanos Par 1 / Deleção Cromossômica / Bortezomib / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Ribossômicas / Cromossomos Humanos Par 1 / Deleção Cromossômica / Bortezomib / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article